VanEck Pharmaceutical ETF
PPHDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 7, 2026 | $0.62 | 2026-07-01 | 2026-07-01 |
| April 7, 2026 | $0.84 | 2026-04-01 | 2026-04-01 |
| December 31, 2025 | $0.31 | 2025-12-29 | 2025-12-29 |
| October 6, 2025 | $0.39 | 2025-10-01 | 2025-10-01 |
| July 7, 2025 | $0.61 | 2025-07-01 | 2025-07-01 |
Dividends Summary
- Consistent Payer: VanEck Pharmaceutical ETF has rewarded shareholders with 61 dividend payments over the past 18 years.
- Total Returned Value: Investors who held PPH shares during this period received a total of $20.05 per share in dividend income.
- Latest Payout: The most recent dividend of $0.62/share was paid 11 days ago, on July 7, 2026.
- Yield & Schedule: PPH currently pays dividends quarterly with an annual yield of 1.97%.
- Dividend Growth: Since 2008, the dividend payout has grown by 62380.0%, from $0.00 to $0.62.
Company News
Vanguard Health Care ETF (VHT) offers broad diversification across 429 healthcare holdings with a low 0.09% expense ratio, while VanEck Pharmaceutical ETF (PPH) provides concentrated exposure to 26 drugmakers with higher returns but greater risk. VHT is more cost-effective and diversified, while PPH has delivered superior 5-year returns and highe...
VanEck Pharmaceutical ETF (PPH) offers a lower expense ratio (0.36%) and higher dividend yield (2.00%), making it ideal for income-focused investors, while Invesco Pharmaceuticals ETF (PJP) delivered stronger 1-year returns (49.90% vs 27.10%) but has higher fees (0.57%). PPH provides global exposure with better 5-year performance, while PJP focus...
Pharmaceutical stocks experienced significant gains after the Trump administration delayed potential drug import tariffs, with major drugmakers striking deals to invest in U.S. manufacturing and avoid potential 100% tariffs.
Economist Justin Wolfers warns that proposed 100% tariffs on foreign pharmaceuticals will likely be passed onto American patients and insurers, particularly for patented brand-name drugs with inelastic demand.
